GlassScriptPhysician profile
Brittany L Lyons
NPI 1255725487
$1,540.62
in general payments reported to CMS, 2019-2025
18 companies · $723 in 2025
The $723 reported for 2025 was more than what 80% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $19.26 · 2021: $27.36 · 2022: $33.14 · 2023: $262 · 2024: $475 · 2025: $723.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,461.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,460.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $335.91 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Boston Scientific Corporation | $199.15 | 2023-2025 | Watchman Flx, Watchman Access System, Spectra Wavewriter |
| Pfizer INC. | $183.88 | 2024-2025 | |
| Janssen Pharmaceuticals, INC | $163.68 | 2023 | Xarelto |
| Exact Sciences Corporation | $134.34 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Lilly USA, LLC | $90.87 | 2024-2025 | Mounjaro, Zepbound |
| Abbvie INC. | $82.55 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $68.71 | 2021-2024 | Eliquis |
| Idorsia Pharmaceuticals US INC | $52.65 | 2024-2025 | Quviviq, Quviviq |
| Abbott Laboratories | $48.73 | 2024-2025 | Eterna, Freestyle Libre 3 |
| Sanofi-Aventis U.S. LLC | $43.91 | 2025 | |
| Sumitomo Pharma America, INC. | $27.81 | 2025 | Gemtesa |
| Astellas Pharma US INC | $23.68 | 2024 | Veozah |
| Allergan, INC. | $19.26 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.04 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $16.49 | 2025 | Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.78 | 2025 | Jardiance |
| Philips North America LLC | $15.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittany Lyons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.